Lee Hoyoung, Choi Tae-Young, Myung Chang-Seon, Lee Myeong Soo
KM Fundamental Research Division, Korea Institute of Oriental Medicine, 483 Expo-ro, Yuseong-gu, Daejeon, 305-811, Republic of Korea.
Department of Pharmacology, Chungnam National University College of Pharmacy, 99 Daehakno, Yuseong-gu, Daejeon, 305-764, Republic of Korea.
Syst Rev. 2016 Jan 20;5:9. doi: 10.1186/s13643-016-0185-9.
Dysmenorrhea is a common gynecological complaint in adolescent and young females. The purpose of this study is to assess the efficacy of Shaofu Zhuyu (SFZY) decoctions as treatments for primary dysmenorrhea.
METHODS/DESIGN: Fifteen (four English, seven Korean, three Chinese, and one Japanese) databases will be searched from their inception without a language restriction. These include PubMed, AMED, EMBASE, The Cochrane Library, seven Korean Medical Databases (Korean Studies Information, DBPIA, Oriental Medicine Advanced Searching Integrated System, Research Information Service System, KoreaMed, The Town Society of Science Technology, and the Korean National Assembly Library), three Chinese Medical Databases [the Chinese Medical Database (CNKI), Chongqing VIP Chinese Science and Technology Periodical Database (VIP), and WanFang Database], and one Japanese Database (J global). Randomized clinical trials (RCTs) included those that examined an SFZY decoction or a modified SFZY decoction. The control groups include no treatment, placebo, and medication. Trials testing a combination of SFZY decoction and medication compare to the same medication alone will be also included. Data extraction and risk of bias assessments will be performed by two independent reviewers. All statistical analyses will be conducted using Review Manager software (RevMan V.5.3.0). Methodological quality will be assessed with the Cochrane risk of bias tool.
This systematic review will provide a detailed summary of the available evidence testing the effects of SFZY decoctions for the treatment of primary dysmenorrhea. The review will benefit patients and practitioners in the fields of traditional and complementary medicine.
PROSPERO registration number: CRD42015016386.
痛经是青少年和年轻女性常见的妇科问题。本研究旨在评估少腹逐瘀汤治疗原发性痛经的疗效。
方法/设计:将检索15个数据库(4个英文数据库、7个韩文数据库、3个中文数据库和1个日文数据库),自数据库创建起,无语言限制。这些数据库包括PubMed、AMED、EMBASE、Cochrane图书馆、7个韩国医学数据库(韩国研究信息库、DBPIA、东方医学高级检索集成系统、研究信息服务系统、KoreaMed、科学技术城镇协会和韩国国会图书馆)、3个中国医学数据库[中国医学数据库(CNKI)、重庆维普中文科技期刊数据库(VIP)和万方数据库]以及1个日本数据库(J global)。随机临床试验(RCT)包括那些研究少腹逐瘀汤或改良少腹逐瘀汤的试验。对照组包括不治疗、安慰剂和药物治疗。比较少腹逐瘀汤与药物联合治疗和单纯相同药物治疗的试验也将纳入。数据提取和偏倚风险评估将由两名独立的评审员进行。所有统计分析将使用Review Manager软件(RevMan V.5.3.0)进行。方法学质量将使用Cochrane偏倚风险工具进行评估。
本系统评价将详细总结现有证据,以检验少腹逐瘀汤治疗原发性痛经的效果。该评价将使传统医学和补充医学领域的患者和从业者受益。
PROSPERO注册号:CRD42015016386。